Global Biosimilar Monoclonal Antibody Market 2022 by Company, Regions, Type and Application, Forecast to 2028
The Biosimilar Monoclonal Antibody market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Biosimilar Monoclonal Antibody market size is estimated to be worth US$ 4706.7 million in 2021 and is forecast to a readjusted size of USD 24410 million by 2028 with a CAGR of 26.5% during review period. Chronic & Autoimmune Diseases accounting for % of the Biosimilar Monoclonal Antibody global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Limited Dilution Method segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Biosimilar Monoclonal Antibody include Biocon, Accord Healthcare, AET Biotech, Amgen, and Celltrion, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Biosimilar Monoclonal Antibody market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Limited Dilution Method
Micromanipulation
Soft Agar Plate Method
Others
Market segment by Application, can be divided into
Chronic & Autoimmune Diseases
Oncology
Others
Market segment by players, this report covers
Biocon
Accord Healthcare
AET Biotech
Amgen
Celltrion
Reddy's Laboratories
Hospira
3SBio
Allergan
Alvartis
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Biosimilar Monoclonal Antibody product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Biosimilar Monoclonal Antibody, with revenue, gross margin and global market share of Biosimilar Monoclonal Antibody from 2019 to 2022.
Chapter 3, the Biosimilar Monoclonal Antibody competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Biosimilar Monoclonal Antibody market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Biosimilar Monoclonal Antibody research findings and conclusion, appendix and data source.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Biosimilar Monoclonal Antibody
1.2 Classification of Biosimilar Monoclonal Antibody by Type
1.2.1 Overview: Global Biosimilar Monoclonal Antibody Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Biosimilar Monoclonal Antibody Revenue Market Share by Type in 2021
1.2.3 Limited Dilution Method
1.2.4 Micromanipulation
1.2.5 Soft Agar Plate Method
1.2.6 Others
1.3 Global Biosimilar Monoclonal Antibody Market by Application
1.3.1 Overview: Global Biosimilar Monoclonal Antibody Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Chronic & Autoimmune Diseases
1.3.3 Oncology
1.3.4 Others
1.4 Global Biosimilar Monoclonal Antibody Market Size & Forecast
1.5 Global Biosimilar Monoclonal Antibody Market Size and Forecast by Region
1.5.1 Global Biosimilar Monoclonal Antibody Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Biosimilar Monoclonal Antibody Market Size by Region, (2017-2022)
1.5.3 North America Biosimilar Monoclonal Antibody Market Size and Prospect (2017-2028)
1.5.4 Europe Biosimilar Monoclonal Antibody Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Biosimilar Monoclonal Antibody Market Size and Prospect (2017-2028)
1.5.6 South America Biosimilar Monoclonal Antibody Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Biosimilar Monoclonal Antibody Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Biosimilar Monoclonal Antibody Market Drivers
1.6.2 Biosimilar Monoclonal Antibody Market Restraints
1.6.3 Biosimilar Monoclonal Antibody Trends Analysis
2 Company Profiles
2.1 Biocon
2.1.1 Biocon Details
2.1.2 Biocon Major Business
2.1.3 Biocon Biosimilar Monoclonal Antibody Product and Solutions
2.1.4 Biocon Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Biocon Recent Developments and Future Plans
2.2 Accord Healthcare
2.2.1 Accord Healthcare Details
2.2.2 Accord Healthcare Major Business
2.2.3 Accord Healthcare Biosimilar Monoclonal Antibody Product and Solutions
2.2.4 Accord Healthcare Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Accord Healthcare Recent Developments and Future Plans
2.3 AET Biotech
2.3.1 AET Biotech Details
2.3.2 AET Biotech Major Business
2.3.3 AET Biotech Biosimilar Monoclonal Antibody Product and Solutions
2.3.4 AET Biotech Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 AET Biotech Recent Developments and Future Plans
2.4 Amgen
2.4.1 Amgen Details
2.4.2 Amgen Major Business
2.4.3 Amgen Biosimilar Monoclonal Antibody Product and Solutions
2.4.4 Amgen Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Amgen Recent Developments and Future Plans
2.5 Celltrion
2.5.1 Celltrion Details
2.5.2 Celltrion Major Business
2.5.3 Celltrion Biosimilar Monoclonal Antibody Product and Solutions
2.5.4 Celltrion Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Celltrion Recent Developments and Future Plans
2.6 Reddy's Laboratories
2.6.1 Reddy's Laboratories Details
2.6.2 Reddy's Laboratories Major Business
2.6.3 Reddy's Laboratories Biosimilar Monoclonal Antibody Product and Solutions
2.6.4 Reddy's Laboratories Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Reddy's Laboratories Recent Developments and Future Plans
2.7 Hospira
2.7.1 Hospira Details
2.7.2 Hospira Major Business
2.7.3 Hospira Biosimilar Monoclonal Antibody Product and Solutions
2.7.4 Hospira Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Hospira Recent Developments and Future Plans
2.8 3SBio
2.8.1 3SBio Details
2.8.2 3SBio Major Business
2.8.3 3SBio Biosimilar Monoclonal Antibody Product and Solutions
2.8.4 3SBio Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 3SBio Recent Developments and Future Plans
2.9 Allergan
2.9.1 Allergan Details
2.9.2 Allergan Major Business
2.9.3 Allergan Biosimilar Monoclonal Antibody Product and Solutions
2.9.4 Allergan Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Allergan Recent Developments and Future Plans
2.10 Alvartis
2.10.1 Alvartis Details
2.10.2 Alvartis Major Business
2.10.3 Alvartis Biosimilar Monoclonal Antibody Product and Solutions
2.10.4 Alvartis Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Alvartis Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Biosimilar Monoclonal Antibody Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Biosimilar Monoclonal Antibody Players Market Share in 2021
3.2.2 Top 10 Biosimilar Monoclonal Antibody Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Biosimilar Monoclonal Antibody Players Head Office, Products and Services Provided
3.4 Biosimilar Monoclonal Antibody Mergers & Acquisitions
3.5 Biosimilar Monoclonal Antibody New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Biosimilar Monoclonal Antibody Revenue and Market Share by Type (2017-2022)
4.2 Global Biosimilar Monoclonal Antibody Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Biosimilar Monoclonal Antibody Revenue Market Share by Application (2017-2022)
5.2 Global Biosimilar Monoclonal Antibody Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Biosimilar Monoclonal Antibody Revenue by Type (2017-2028)
6.2 North America Biosimilar Monoclonal Antibody Revenue by Application (2017-2028)
6.3 North America Biosimilar Monoclonal Antibody Market Size by Country
6.3.1 North America Biosimilar Monoclonal Antibody Revenue by Country (2017-2028)
6.3.2 United States Biosimilar Monoclonal Antibody Market Size and Forecast (2017-2028)
6.3.3 Canada Biosimilar Monoclonal Antibody Market Size and Forecast (2017-2028)
6.3.4 Mexico Biosimilar Monoclonal Antibody Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Biosimilar Monoclonal Antibody Revenue by Type (2017-2028)
7.2 Europe Biosimilar Monoclonal Antibody Revenue by Application (2017-2028)
7.3 Europe Biosimilar Monoclonal Antibody Market Size by Country
7.3.1 Europe Biosimilar Monoclonal Antibody Revenue by Country (2017-2028)
7.3.2 Germany Biosimilar Monoclonal Antibody Market Size and Forecast (2017-2028)
7.3.3 France Biosimilar Monoclonal Antibody Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Biosimilar Monoclonal Antibody Market Size and Forecast (2017-2028)
7.3.5 Russia Biosimilar Monoclonal Antibody Market Size and Forecast (2017-2028)
7.3.6 Italy Biosimilar Monoclonal Antibody Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Biosimilar Monoclonal Antibody Revenue by Type (2017-2028)
8.2 Asia-Pacific Biosimilar Monoclonal Antibody Revenue by Application (2017-2028)
8.3 Asia-Pacific Biosimilar Monoclonal Antibody Market Size by Region
8.3.1 Asia-Pacific Biosimilar Monoclonal Antibody Revenue by Region (2017-2028)
8.3.2 China Biosimilar Monoclonal Antibody Market Size and Forecast (2017-2028)
8.3.3 Japan Biosimilar Monoclonal Antibody Market Size and Forecast (2017-2028)
8.3.4 South Korea Biosimilar Monoclonal Antibody Market Size and Forecast (2017-2028)
8.3.5 India Biosimilar Monoclonal Antibody Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Biosimilar Monoclonal Antibody Market Size and Forecast (2017-2028)
8.3.7 Australia Biosimilar Monoclonal Antibody Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Biosimilar Monoclonal Antibody Revenue by Type (2017-2028)
9.2 South America Biosimilar Monoclonal Antibody Revenue by Application (2017-2028)
9.3 South America Biosimilar Monoclonal Antibody Market Size by Country
9.3.1 South America Biosimilar Monoclonal Antibody Revenue by Country (2017-2028)
9.3.2 Brazil Biosimilar Monoclonal Antibody Market Size and Forecast (2017-2028)
9.3.3 Argentina Biosimilar Monoclonal Antibody Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Biosimilar Monoclonal Antibody Revenue by Type (2017-2028)
10.2 Middle East & Africa Biosimilar Monoclonal Antibody Revenue by Application (2017-2028)
10.3 Middle East & Africa Biosimilar Monoclonal Antibody Market Size by Country
10.3.1 Middle East & Africa Biosimilar Monoclonal Antibody Revenue by Country (2017-2028)
10.3.2 Turkey Biosimilar Monoclonal Antibody Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Biosimilar Monoclonal Antibody Market Size and Forecast (2017-2028)
10.3.4 UAE Biosimilar Monoclonal Antibody Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Biosimilar Monoclonal Antibody Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Biosimilar Monoclonal Antibody Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Biosimilar Monoclonal Antibody Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Biosimilar Monoclonal Antibody Revenue (USD Million) by Region (2017-2022)
Table 5. Global Biosimilar Monoclonal Antibody Revenue Market Share by Region (2023-2028)
Table 6. Biocon Corporate Information, Head Office, and Major Competitors
Table 7. Biocon Major Business
Table 8. Biocon Biosimilar Monoclonal Antibody Product and Solutions
Table 9. Biocon Biosimilar Monoclonal Antibody Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Accord Healthcare Corporate Information, Head Office, and Major Competitors
Table 11. Accord Healthcare Major Business
Table 12. Accord Healthcare Biosimilar Monoclonal Antibody Product and Solutions
Table 13. Accord Healthcare Biosimilar Monoclonal Antibody Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. AET Biotech Corporate Information, Head Office, and Major Competitors
Table 15. AET Biotech Major Business
Table 16. AET Biotech Biosimilar Monoclonal Antibody Product and Solutions
Table 17. AET Biotech Biosimilar Monoclonal Antibody Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Amgen Corporate Information, Head Office, and Major Competitors
Table 19. Amgen Major Business
Table 20. Amgen Biosimilar Monoclonal Antibody Product and Solutions
Table 21. Amgen Biosimilar Monoclonal Antibody Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Celltrion Corporate Information, Head Office, and Major Competitors
Table 23. Celltrion Major Business
Table 24. Celltrion Biosimilar Monoclonal Antibody Product and Solutions
Table 25. Celltrion Biosimilar Monoclonal Antibody Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Reddy's Laboratories Corporate Information, Head Office, and Major Competitors
Table 27. Reddy's Laboratories Major Business
Table 28. Reddy's Laboratories Biosimilar Monoclonal Antibody Product and Solutions
Table 29. Reddy's Laboratories Biosimilar Monoclonal Antibody Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Hospira Corporate Information, Head Office, and Major Competitors
Table 31. Hospira Major Business
Table 32. Hospira Biosimilar Monoclonal Antibody Product and Solutions
Table 33. Hospira Biosimilar Monoclonal Antibody Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. 3SBio Corporate Information, Head Office, and Major Competitors
Table 35. 3SBio Major Business
Table 36. 3SBio Biosimilar Monoclonal Antibody Product and Solutions
Table 37. 3SBio Biosimilar Monoclonal Antibody Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Allergan Corporate Information, Head Office, and Major Competitors
Table 39. Allergan Major Business
Table 40. Allergan Biosimilar Monoclonal Antibody Product and Solutions
Table 41. Allergan Biosimilar Monoclonal Antibody Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Alvartis Corporate Information, Head Office, and Major Competitors
Table 43. Alvartis Major Business
Table 44. Alvartis Biosimilar Monoclonal Antibody Product and Solutions
Table 45. Alvartis Biosimilar Monoclonal Antibody Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Global Biosimilar Monoclonal Antibody Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 47. Global Biosimilar Monoclonal Antibody Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 48. Breakdown of Biosimilar Monoclonal Antibody by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Biosimilar Monoclonal Antibody Players Head Office, Products and Services Provided
Table 50. Biosimilar Monoclonal Antibody Mergers & Acquisitions in the Past Five Years
Table 51. Biosimilar Monoclonal Antibody New Entrants and Expansion Plans
Table 52. Global Biosimilar Monoclonal Antibody Revenue (USD Million) by Type (2017-2022)
Table 53. Global Biosimilar Monoclonal Antibody Revenue Share by Type (2017-2022)
Table 54. Global Biosimilar Monoclonal Antibody Revenue Forecast by Type (2023-2028)
Table 55. Global Biosimilar Monoclonal Antibody Revenue by Application (2017-2022)
Table 56. Global Biosimilar Monoclonal Antibody Revenue Forecast by Application (2023-2028)
Table 57. North America Biosimilar Monoclonal Antibody Revenue by Type (2017-2022) & (USD Million)
Table 58. North America Biosimilar Monoclonal Antibody Revenue by Type (2023-2028) & (USD Million)
Table 59. North America Biosimilar Monoclonal Antibody Revenue by Application (2017-2022) & (USD Million)
Table 60. North America Biosimilar Monoclonal Antibody Revenue by Application (2023-2028) & (USD Million)
Table 61. North America Biosimilar Monoclonal Antibody Revenue by Country (2017-2022) & (USD Million)
Table 62. North America Biosimilar Monoclonal Antibody Revenue by Country (2023-2028) & (USD Million)
Table 63. Europe Biosimilar Monoclonal Antibody Revenue by Type (2017-2022) & (USD Million)
Table 64. Europe Biosimilar Monoclonal Antibody Revenue by Type (2023-2028) & (USD Million)
Table 65. Europe Biosimilar Monoclonal Antibody Revenue by Application (2017-2022) & (USD Million)
Table 66. Europe Biosimilar Monoclonal Antibody Revenue by Application (2023-2028) & (USD Million)
Table 67. Europe Biosimilar Monoclonal Antibody Revenue by Country (2017-2022) & (USD Million)
Table 68. Europe Biosimilar Monoclonal Antibody Revenue by Country (2023-2028) & (USD Million)
Table 69. Asia-Pacific Biosimilar Monoclonal Antibody Revenue by Type (2017-2022) & (USD Million)
Table 70. Asia-Pacific Biosimilar Monoclonal Antibody Revenue by Type (2023-2028) & (USD Million)
Table 71. Asia-Pacific Biosimilar Monoclonal Antibody Revenue by Application (2017-2022) & (USD Million)
Table 72. Asia-Pacific Biosimilar Monoclonal Antibody Revenue by Application (2023-2028) & (USD Million)
Table 73. Asia-Pacific Biosimilar Monoclonal Antibody Revenue by Region (2017-2022) & (USD Million)
Table 74. Asia-Pacific Biosimilar Monoclonal Antibody Revenue by Region (2023-2028) & (USD Million)
Table 75. South America Biosimilar Monoclonal Antibody Revenue by Type (2017-2022) & (USD Million)
Table 76. South America Biosimilar Monoclonal Antibody Revenue by Type (2023-2028) & (USD Million)
Table 77. South America Biosimilar Monoclonal Antibody Revenue by Application (2017-2022) & (USD Million)
Table 78. South America Biosimilar Monoclonal Antibody Revenue by Application (2023-2028) & (USD Million)
Table 79. South America Biosimilar Monoclonal Antibody Revenue by Country (2017-2022) & (USD Million)
Table 80. South America Biosimilar Monoclonal Antibody Revenue by Country (2023-2028) & (USD Million)
Table 81. Middle East & Africa Biosimilar Monoclonal Antibody Revenue by Type (2017-2022) & (USD Million)
Table 82. Middle East & Africa Biosimilar Monoclonal Antibody Revenue by Type (2023-2028) & (USD Million)
Table 83. Middle East & Africa Biosimilar Monoclonal Antibody Revenue by Application (2017-2022) & (USD Million)
Table 84. Middle East & Africa Biosimilar Monoclonal Antibody Revenue by Application (2023-2028) & (USD Million)
Table 85. Middle East & Africa Biosimilar Monoclonal Antibody Revenue by Country (2017-2022) & (USD Million)
Table 86. Middle East & Africa Biosimilar Monoclonal Antibody Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Biosimilar Monoclonal Antibody Picture
Figure 2. Global Biosimilar Monoclonal Antibody Revenue Market Share by Type in 2021
Figure 3. Limited Dilution Method
Figure 4. Micromanipulation
Figure 5. Soft Agar Plate Method
Figure 6. Others
Figure 7. Biosimilar Monoclonal Antibody Revenue Market Share by Application in 2021
Figure 8. Chronic & Autoimmune Diseases Picture
Figure 9. Oncology Picture
Figure 10. Others Picture
Figure 11. Global Biosimilar Monoclonal Antibody Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 12. Global Biosimilar Monoclonal Antibody Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Biosimilar Monoclonal Antibody Revenue Market Share by Region (2017-2028)
Figure 14. Global Biosimilar Monoclonal Antibody Revenue Market Share by Region in 2021
Figure 15. North America Biosimilar Monoclonal Antibody Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Europe Biosimilar Monoclonal Antibody Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Asia-Pacific Biosimilar Monoclonal Antibody Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. South America Biosimilar Monoclonal Antibody Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Middle East and Africa Biosimilar Monoclonal Antibody Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Biosimilar Monoclonal Antibody Market Drivers
Figure 21. Biosimilar Monoclonal Antibody Market Restraints
Figure 22. Biosimilar Monoclonal Antibody Market Trends
Figure 23. Biocon Recent Developments and Future Plans
Figure 24. Accord Healthcare Recent Developments and Future Plans
Figure 25. AET Biotech Recent Developments and Future Plans
Figure 26. Amgen Recent Developments and Future Plans
Figure 27. Celltrion Recent Developments and Future Plans
Figure 28. Reddy's Laboratories Recent Developments and Future Plans
Figure 29. Hospira Recent Developments and Future Plans
Figure 30. 3SBio Recent Developments and Future Plans
Figure 31. Allergan Recent Developments and Future Plans
Figure 32. Alvartis Recent Developments and Future Plans
Figure 33. Global Biosimilar Monoclonal Antibody Revenue Share by Players in 2021
Figure 34. Biosimilar Monoclonal Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 35. Global Top 3 Players Biosimilar Monoclonal Antibody Revenue Market Share in 2021
Figure 36. Global Top 10 Players Biosimilar Monoclonal Antibody Revenue Market Share in 2021
Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 38. Global Biosimilar Monoclonal Antibody Revenue Share by Type in 2021
Figure 39. Global Biosimilar Monoclonal Antibody Market Share Forecast by Type (2023-2028)
Figure 40. Global Biosimilar Monoclonal Antibody Revenue Share by Application in 2021
Figure 41. Global Biosimilar Monoclonal Antibody Market Share Forecast by Application (2023-2028)
Figure 42. North America Biosimilar Monoclonal Antibody Sales Market Share by Type (2017-2028)
Figure 43. North America Biosimilar Monoclonal Antibody Sales Market Share by Application (2017-2028)
Figure 44. North America Biosimilar Monoclonal Antibody Revenue Market Share by Country (2017-2028)
Figure 45. United States Biosimilar Monoclonal Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Canada Biosimilar Monoclonal Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Mexico Biosimilar Monoclonal Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Europe Biosimilar Monoclonal Antibody Sales Market Share by Type (2017-2028)
Figure 49. Europe Biosimilar Monoclonal Antibody Sales Market Share by Application (2017-2028)
Figure 50. Europe Biosimilar Monoclonal Antibody Revenue Market Share by Country (2017-2028)
Figure 51. Germany Biosimilar Monoclonal Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. France Biosimilar Monoclonal Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. United Kingdom Biosimilar Monoclonal Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Russia Biosimilar Monoclonal Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Italy Biosimilar Monoclonal Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Asia-Pacific Biosimilar Monoclonal Antibody Sales Market Share by Type (2017-2028)
Figure 57. Asia-Pacific Biosimilar Monoclonal Antibody Sales Market Share by Application (2017-2028)
Figure 58. Asia-Pacific Biosimilar Monoclonal Antibody Revenue Market Share by Region (2017-2028)
Figure 59. China Biosimilar Monoclonal Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan Biosimilar Monoclonal Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South Korea Biosimilar Monoclonal Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India Biosimilar Monoclonal Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia Biosimilar Monoclonal Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia Biosimilar Monoclonal Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America Biosimilar Monoclonal Antibody Sales Market Share by Type (2017-2028)
Figure 66. South America Biosimilar Monoclonal Antibody Sales Market Share by Application (2017-2028)
Figure 67. South America Biosimilar Monoclonal Antibody Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Biosimilar Monoclonal Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Biosimilar Monoclonal Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East and Africa Biosimilar Monoclonal Antibody Sales Market Share by Type (2017-2028)
Figure 71. Middle East and Africa Biosimilar Monoclonal Antibody Sales Market Share by Application (2017-2028)
Figure 72. Middle East and Africa Biosimilar Monoclonal Antibody Revenue Market Share by Country (2017-2028)
Figure 73. Turkey Biosimilar Monoclonal Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Biosimilar Monoclonal Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. UAE Biosimilar Monoclonal Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Methodology
Figure 77. Research Process and Data Source
